Precision Oncology – Innovative diagnostic and therapeutic approaches and their social-economic impact

Event overview
  • September 25, 2018, 3:30 pm–8:00 pm
  • Auditorium - University Hospital Heidelberg,
    Center for Internal Medicine,
    Im Neuenheimer Feld 410,
    69120 Heidelberg,
    Germany
  • Event Website

This event is in the past

HEALTH AXIS EUROPE VISIONARY SEMINAR – Heidelberg and Leuven

The field of oncology is leading the precision medicine revolution. Heidelberg and Leuven present some of the most promising novel approaches in research from academia and industry. Eminent speakers discuss reimbursement challenges and policies, and cost-based pricing versus value-based pricing, from a patient, pharma, payor, and molecular diagnostics perspective.

SPEAKERS:

  • Frank Ulrich Montgomery, President of the German Medical Association
  • Andree Blaukat, Merck
  • Michel Delforge, Leuven Cancer Institute
  • Katelijne De Nys, Belgian Commission for the Reimbursement of Medicines
  • Liesbet Lagae, Program Director Life Science Technologies at IMEC
  • Diether Lambrechts, VIB-KU Leuven Center for Cancer Biology
  • Michael Schlander, German Cancer Research Center
  • Özlem Türeci, Ci3 e.V. and Ganymed
  • Olaf Witt, Hopp Children’s Cancer Center at the NCT (KiTZ)

VENUE: Auditorium – University Hospital Heidelberg – Center for Internal Medicine,
Im Neuenheimer Feld 410, Heidelberg

Registration

Programme and Registration at www.biorn.org

Back to top
Image of

Close